Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.16145 | 94 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.20476 | 94 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.20393 | 94 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.59282 | 91 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.20216 | 94 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.23831 | 95 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.09072 | 95 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.18732 | 94 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.81349 | 93 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.20998 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.28933 | 95 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.37921 | 95 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.42995 | 95 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.27523 | 95 |